Delhi Bans Adulterated Coldrif Cough Syrup
The Delhi government has prohibited the sale, purchase, and distribution of Coldrif cough syrup after it was found to contain harmful levels of Diethylene Glycol. The syrup, manufactured in May 2025 by Sresan Pharmaceutical, was deemed unsafe. Stakeholders are urged to comply, and public advisories have been widely disseminated.
- Country:
- India
The Delhi government has announced a ban on the sale, purchase, and distribution of Coldrif cough syrup following an official declaration that the product is 'not of standard quality.'
The product, manufactured by Sresan Pharmaceutical Manufacturer in May 2025, was found to contain 46.28% w/v of Diethylene Glycol, a toxic substance.
Authorities have instructed all parties to cease dealings with the product immediately, and the public is advised against its use due to significant health risks. Cooperation from all stakeholders is essential for the effective enforcement of this advisory.
(With inputs from agencies.)
Advertisement
ALSO READ
Toxic Alert in Manipur: Banned Cough Syrups Contain Lethal Solvent
Supreme Court to Hear PIL on Toxic Cough Syrup Deaths
Tragic Toll: Toxic Syrup Causes Child Deaths, Factory Owner Arrested
Pharma Firm Owner Arrested in Toxic Cough Syrup Scandal
Top Health Headlines: NYC Lawsuit, Toxic Cough Syrups, and Vaccine Panel Delay
Google News